New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 1, 2013
16:05 EDTPDLIPDL BioPharma reports Q4 EPS 34c, consensus 32c
Reports Q4 revenue $86.0M, consensus $86.08M.
News For PDLI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 19, 2014
07:09 EDTPDLIJefferies to hold a conference
2014 Global London Healthcare Conference is being held in London, England on November 19-20.
November 14, 2014
07:02 EDTPDLIPDL BioPharma announces conclusion of revenue interest agreement with AxoGen
PDL BioPharma (PDLI) announced that the company has received $30.3M, in addition to previously received revenue interest payments, to conclude PDL's revenue interest agreement with AxoGen (AXGN). In October 2012, PDL entered into a structured financing transaction in which PDL provided AxoGen with an aggregate of $20.8M in exchange for royalties on certain AxoGen revenues.
November 10, 2014
16:11 EDTPDLIPDL BioPharma reports Q3 EPS 61c, consensus 56c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use